Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ray Co., Ltd. (228670:KRX), powered by AI.
Ray Co., Ltd. is currently trading at ₩6,490. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ray Co., Ltd. on Alpha Lenz.
Ray Co., Ltd.'s P/E ratio is -1.7.
“Ray Co., Ltd. trades at a P/E of -1.7 (undervalued) with modest ROE of -60.2%.”
Ask for details →Ray Co., Ltd. is a prominent player in the aerospace and defense sector, specializing in the production and development of cutting-edge technologies used in advanced manufacturing applications. The company's primary focus is on providing high-precision components and systems that contribute to the efficiency and innovation within the aerospace industry. Through its engineering capabilities, Ray Co., Ltd. plays a vital role in supplying parts and systems that meet stringent safety and performance standards required in aerospace operations. The expertise of Ray Co., Ltd. extends across various sub-sectors including aircraft systems, defense equipment, and specialized engineering solutions, thereby impacting both commercial and military aviation markets significantly. By emphasizing research and development, Ray Co., Ltd. ensures that it remains at the forefront of technological advancements in aerospace materials and processes. This strategic emphasis not only boosts the company's market significance but also supports its position as a trusted partner for major aerospace manufacturers globally. Ray Co., Ltd. is committed to innovation and quality, making it a crucial entity in supporting technological advancements in aerospace engineering.
“Ray Co., Ltd. trades at a P/E of -1.7 (undervalued) with modest ROE of -60.2%.”
Ask for details →Ray Co., Ltd. (ticker: 228670) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 176 employees. Market cap is $101.3B.
The current price is ₩6,490 with a P/E ratio of -1.68x and P/B of 1.38x.
ROE is -60.23% and operating margin is -55.43%. Annual revenue is $79.8B.